Izaki M, Yasunaga JI, Nosaka K, Sugata K, Utsunomiya H, Suehiro Y, Shichijo T, Yamada A, Sugawara Y, Hibi T, Inomata Y, Akari H, Melamed A, Bangham C, Matsuoka M.

In vivo dynamics and adaptation of HTV-１-infected clones under different clinical conditions

PLOS Pathogens.2021 Feb 1;17(2):e1009271. doi: 10.1371/journal.ppat.1009271. Online ahead of print .PMID: 33524072

https://pubmed.ncbi.nlm.nih.gov/33524072/

Nozaki K, Maruyama D, Maeshima AM, Tajima K, Itami J, Shichijo T, Yuda S, Suzuki T, Toyoda K, Yamauchi N, Makita S, Fukuhara S, Munakata W, Kobayashi Y, Taniguchi H, Izutsu K and Tobinai K.

The role of local radiotherapy following rituximab-containing chemotherapy in patients with transformed indolent B-cell lymphoma.

Eur J Haematol 106(2): 213-220. doi: 10.1111/ejh.13539. Epub 2020 Nov 6.

https://pubmed.ncbi.nlm.nih.gov/33098704/

Jang JH, Tomiyama Y, Miyazaki K, Nagafuji K, Usuki K, Uoshima N, Fujisaki T, Kosugi K, Matsumura I, Sasaki K, Kizaki M, Sawa M, Hidaka M, Kobayashi N, Ichikawa S, Yonemura Y, Enokitani K, Matsuda A, Ozawa K, Mitani K, Lee JW, Nakao S.

Efficacy and safety of romiplostim refractory aplastic anemia: a phase 2/3, multicentre, open-label study.

Brit J Haematol 192(1):190-199,2021. doi: 10.1111/bjh.17190. Epub 2020 Nov 5.

https://pubmed.ncbi.nlm.nih.gov/33152120/

Maeda M, Muraki Y, Kosaka T, Yamada T, Aoki Y, Kaku M, Seki M, Tanabe Y, Fujita N, Niki Y, Morita K, Yanagihara K, Yoshida K, Kawaguchi T.

Impact of health policy on structural requisites for antimicrobial stewardship: A nationwide survey conducted in Japanese hospitals after enforcing the revised reimbursement system for antimicrobial stewardship programs.

J Infect Chemother 27(1):1-6,2021. doi: 10.1016/j.jiac.2020.09.015.

https://pubmed.ncbi.nlm.nih.gov/33008739/

Sakata K, Yasuoka H, Yoshimoto K, Takeuchi T.

Refractory IgG4-related Pleural Disease with Chylothorax: A Case Report and Literature Review.

Intern Med Online ahead of print,2021.  doi: 10.1093/rheumatology/keaa312.

https://pubmed.ncbi.nlm.nih.gov/32743653/

Shichijo T, Maruyama D, Yamauchi N, Maeshima AM, Sugano M, Yuda S, Tajima K, Kurihara H, Shimada K, Suzuki T, Toyoda K, Makita S, Fukuhara S, Munakata W, Suzuki T, Kobayashi Y, Taniguchi H, Minami Y, Izutsu K and Tobinai K.

Transformation Scoring System (TSS): A new assessment index for clinical transformation of follicular lymphoma.

Cancer Med 9(23): 8864-8874. doi: 10.1002/cam4.3501. Epub 2020 Oct 6.

https://pubmed.ncbi.nlm.nih.gov/33022120/

Sato E, Iriyama N, Tokuhira M, Takaku T, Ishikawa M, Nakazato T, Sugimoto KJ, Fujita H, Kimura Y, Fujioka I, Asou N, Komatsu N, Kizaki M, Hatta Y, Kawaguchi T.

The EUTOS long-term survival score predicts disease-specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice-based cohort.

Cancer Med 9(23): 8931-8939,2020. doi: 10.1002/cam4.3516. Epub 2020 Oct 10.

https://pubmed.ncbi.nlm.nih.gov/33037866/

Tanaka A, Ishitsuka Y, Ohta H, Fujimoto A, Yasunaga JI, Matsuoka M.

Systematic clustering algorithm for chromatin accessibility data and its application to hematopoietic cells.

PLOS Comput Biol 16(11):e1008422. doi: 10.1371/journal.pcbi.1008422. eCollection 2020 Nov.

https://pubmed.ncbi.nlm.nih.gov/33253153/

Hashiguchi Y, Oda K, Katanoda T, Nosaka K, Jono H and Saito H

Clinical evaluation of cefotiam in the treatment of bacteremia caused by Escherichia coli, Klebsiella species, and Proteus mirabilis: A retrospective study.

J Infect Chemother 26(11):1158-1163. doi: 10.1016/j.jiac.2020.06.007. Epub 2020 Aug 20.

https://pubmed.ncbi.nlm.nih.gov/32828676/

Kondo Y, Suzuki K, Inoue Y, Sakata K, Takahashi C, Kaneko Y, Takeuchi T.

Safety and tolerability of ultrasound-guided synovial needle biopsy in Japanese arthritis patients.

Mod Rheumatol Online ahead of print. 20:1-9,2020. doi: 10.1080/14397595.2020.1847754.

https://pubmed.ncbi.nlm.nih.gov/33155872/

Kimura Y, Iwanaga E, Iwanaga K, Endo S, Inoue Y, Tokunaga K, Nagahata Y, Masuda K, Kawamoto H, Matsuoka M.

A regulatory element in the 3′-untranslated region of CEBPA is associated with myeloid/NK/T-cell leukemia.

Eur J Haematol. 2020 Nov 16.doi:10.1111/ejh.13551. PMID:33197296

https://pubmed.ncbi.nlm.nih.gov/33197296/

Imaizumi Y, Iwanaga M, Nosaka K, Ishitsuka K, Ishizawa K, Ito S, Amano M, Ishida T, Uike N, Utsunomiya A, Ohshima K, Tanaka J, Tokura Y, Tobinai K, Watanabe T, Uchimaru K and Tsukasaki K for collaborative Investigators.

Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.

Cancer Sci 111(12): 4567-4580. doi: 10.1111/cas.14658. Epub 2020 Oct 21.

https://pubmed.ncbi.nlm.nih.gov/32976684/

Yonekura K, Kusumoto S, Choi I, Nakano N, Ito A, Suehiro Y, Imaizumi Y, Yoshimitsu M, Nosaka K, Ohtsuka E, Hidaka M, Jo T. Sasaki H, Moriuchi Y, Ogata M, Tatetsu H, Ishitsuka K, Miyazaki Y, Ueda R, Utsunomiya A, Ishida T.

Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study.

Blood A dv 4(20):5133-5145,2020. doi: 10.1182/bloodadvances.2020003053.

https://pubmed.ncbi.nlm.nih.gov/33091125/

Yonekura K, Kusumoto S, Choi I, Nakano N, Ito A, Suehiro Y, Imaizumi Y, Yoshimitsu M, Nosaka K, Ohtsuka E, Hidaka M, Jo T. Sasaki H, Moriuchi Y, Ogata M, Tatetsu H, Ishitsuka K, Miyazaki Y, Ueda R, Utsunomiya A, Ishida T.

Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study.

Blood A dv 4(20):5133-5145,2020. doi: 10.1182/bloodadvances. 2020003053.

https://pubmed.ncbi.nlm.nih.gov/33091125/

Hosokawa K, Ishiyama K, Ikemoto T, Sugimori C, Noji H, Shichishima T, Obara N, Chiba S, Ninomiya H, Nguyen MAT, Shirasugi Y, Nakamura Y, Ando K, Ueda Y, Yonemura Y, Kawaguchi T, Nishimura J, Kanakura Y, Nakao S.

The clinical significance of PNH-phenotype cells accounting for < 0.01% of total granulocytes detected by the Clinical and Laboratory Standards Institute methods in patients with bone marrow failure.

Ann Hematol Online ahead of print,2020. doi: 10.1007/s00277-020-04314-w

https://pubmed.ncbi.nlm.nih.gov/33095337/

Matsumura T, Nakamura-Ishizu A, Muddineni SSNA, Tan DQ, Wang CO, Tokunaga K,Tirado-Magallanes R, Sian S, Benoukraf T, Okuda T, Asou N, Matsuoka M, Osato M, Suda T.

Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia.

Blood 136:1919-1932,2020. doi: 10.1182/blood.2019004292.

https://pubmed.ncbi.nlm.nih.gov/32573733/

Matsumura T, Nakamura-Ishizu A, Muddineni SSNA, Tan DQ, Wang CQ, Tokunaga K, Tirado-Magallanes R, Sian S, Benoukraf T, Okuda T, Asou N, Matsuoka M, Osato M, Suda T

Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia.

Blood 136(17):1919-1932,2020. doi: 10.1182/blood.2019004292.

https://pubmed.ncbi.nlm.nih.gov/32573733/

Yanagawa Y, Shimogawara R, Endo T, Fukushima R, Gatanaga H, Hayasaka K, Kikuchi Y, Kobayashi T, Koga M, Koibuchi T, Miyagawa T, Nagata A, Nakata H, Oka S, Otsuka R, Sakai K, Shibuya M, Shingyochi H, Tsuchihashi E, Watanabe K, Yagita K.

Utility of the Rapid Antigen Detection Test E. histolytica Quik Chek for the Diagnosis of Entamoeba histolytica Infection in Nonendemic Situations.

J Clin Microbiol 58(11):e01991-20,2020. doi: 10.1128/JCM.01991-20. Print 2020 Oct 21.

https://pubmed.ncbi.nlm.nih.gov/32878955/

Kagami Y, Yamamoto K, Shibata T, Tobinai K, Imaizumi Y, Uchida T, Shimada K, Minauchi K, Fukuhara N, Kobayashi H, Yamauchi N, Tsujimura H, Hangaishi A, Tominaga R, Suehiro Y, Yoshida S, Inoue Y, Suzuki S, Tokuhira M, Kusumoto S, Kuroda J, Yakushijin Y, Takamatsu Y, KubotaY, Nosaka K, Morishima S, Nakamura S, Ogura M, Maruyama D, Hotta T, Morishima Y, Tsukasaki K, Nagai H.

R-CHOP-14 versus R-CHOP-14/CHASER for upfront autologous transplantation in diffuse large B-cell lymphoma:JCOG0908 study.

Cancer Sci 111(10):3770-3779,2020. doi: 10.1111/cas.14604. Epub 2020 Sep 11.

https://pubmed.ncbi.nlm.nih.gov/32767806/

Oda K, Jono H, Nosaka K and Saito H.

Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration.

Int J Antimicrob Agents 56: 106109,2020. doi: 10.1016/j.ijantimicag.2020.106109.

https://pubmed.ncbi.nlm.nih.gov/32721597/

Sekiguchi N, Rai S, Munakata W, Suzuki K, Handa H, Shibayama H, Endo T, Terui Y, Iwaki N, Fukuhara N, Tatetsu H, Iida S, Ishikawa T, Shiibashi R, Izutsu K.

A multicenter, open-label, phase II study of tirabrutinib (ONO/GS-4059) in patients with Waldenström’s macroglobulinemia.

Cancer Sci 111(9):3327-3337,2020. doi: 10.1111/cas.14561. Epub 2020 Jul 20.

https://pubmed.ncbi.nlm.nih.gov/32639651/

Shimoda K, Takahashi N, Kirito K, Iriyama N, Kawaguchi T, Kizaki M

JSH Practical Guidelines for Hematological Malignancies, 2018: I. Leukemia-4. Chronic myeloid leukemia (CML)/myeloproliferative neoplasms (MPN).

Int J Hematol 112 (3): 268-291,2020. doi: 10.1007/s12185-020-02964-0. Epub 2020 Aug 11.

https://pubmed.ncbi.nlm.nih.gov/32783166/

Okuma K, Kuramitsu M, Niwa T, Taniguchi T, Masaki Y, Ueda G, Matsumoto C, Sobata R, Sagara Y, Nakamura H, Satake M, Miura K, Fuchi N, Masuzaki H, Okayama A, Umeki K, Yamano Y, Sato T, Iwanaga M, Uchimaru K, Nakashima M, Utsunomiya A, Kubota R, Ishitsuka K, Hasegawa H, Sasaki D, Koh KR, Taki M, Nosaka K, Ogata M, Naruse I, Kaneko N, Okajima S, Tezuka K, Ikebe E, Matsuoka S, Itabashi K, Saito S, Watanabe T and Hamaguchi I

Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan.

Retrovirology 17(1):26, 2020. doi: 10.1186/s12977-020-00534-0.

https://pubmed.ncbi.nlm.nih.gov/32831150/